| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |